Table 3.
PCs that display statistically significant differences between tissue diagnosed with dysplasia/CIS and normal tissues based on unpaired Wilcoxon Rank Sum tests of PCs derived from spectra measured with the (a) shielded and (b) unshielded probe geometries. The PCs were derived from either the original spectra (original), spectra preprocessed by normalization to the peak (peak) or normalization to the area (area). Each PC is shown for the highest significance level (lowest p-value) that it satisfies.
| (a) | ||||||
|---|---|---|---|---|---|---|
| Normalization Technique | Original | Peak | Area | Peak | Area | |
| p-value | p<0.05 | p<0.005 | ||||
| Excitation Wavelength (nm) | 300 | PC2 | PC3 | |||
| PC3 | ||||||
| 320 | PC1 | PC1 | PC4 | PC1 | ||
| PC2 | ||||||
| PC3 | ||||||
| 340 | PC1 | PC1 | PC3 | PC1 | ||
| PC2 | ||||||
| 370 | PC2 | PC2 | PC1 | PC1 | ||
| PC5 | PC5 | |||||
| 410 | PC2 | PC2 | ||||
| 460 | ||||||
| Reflectance (300–550 nm) | No reflectance measurements were made with the shielded probe | |||||
| (b) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Normalization Technique | Original | Peak | Area | Original | Peak | Area | Original | Peak | Area | |
| p-value | p<0.05 | p<0.005 | p<0.0005 | |||||||
| Excitation Wavelength (nm) | 300 | PC1 | PC1 | PC1 | PC3 | |||||
| 320 | PC1 | PC1 | PC1 | PC2 | PC2 | |||||
| 340 | PC2 | PC1 | PC2 | PC1 | PC1 | |||||
| PC2 | ||||||||||
| 370 | PC1 | PC1 | ||||||||
| 410 | PC2 | PC2 | PC3 | PC3 | ||||||
| 460 | ||||||||||
| Reflectance (300–550 nm) | PC4 | PC3 | PC4 | PC3 | PC1 | |||||